Determination of fentanyl in sweat and hair of a patient using transdermal patches

Journal of Analytical Toxicology

Volumn 32, Issue 3, 2008, Pages 260-264

  Schneider, Serge ^a   Ait m bark, Zahra ^a   Schummer, Claude ^a   Lemmer, Patrick ^a   Yegles, Michel ^a   Appenzeller, Brice ^b   Wennig, Robert ^a  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^b LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; FENTANYL;

ACCURACY; ADULT; ARTICLE; CASE REPORT; CHRONIC PAIN; DRUG DETERMINATION; DRUG HAIR LEVEL; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MALE; STANDARD; SWEAT; TANDEM MASS SPECTROMETRY; TOOTH PAIN; TRANSDERMAL PATCH;

EID: 41749111102     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/32.3.260     Document Type: Article

References (34)

1. C.A. Kornick, J. Santiago-Palma, N. Moryl, R. Payne, and E.A. Obbens. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf. 26: 951-973 (2003).
2. S. Bracht. Transdermal therapeutic systems: a review. Innovations in Pharmaceutical Technology: 92-98 (2000).
3. T.L. Skaer. Transdermal opioids for cancer pain. Health Qual Life Outcomes 4: 24 (2006).
4. G. Herrero-Beaumont, O. Bjorneboe, and U. Richarz. Transdermal fentanyl for the treatment of pain caused by rheumatoid arthritis. Rheumatol. Int. 24: 325-332 (2004).
5. B. Ben-David, R. Frankel, T. Arzumonov, Y. Marchevsky, and G. Volpin. Minidose bupivacaine-fentanyl spinal anesthesia for surgical repair of hip fracture in the aged. Anesthesiology 92: 6-10 (2000).
6. P.J. Koo. Postoperative pain management with a patient-controlled transdermal delivery system for fentanyl. Am. J. Health Syst. Pharm. 62: 1171-1176 (2005).
7. R. Sinatra. The fentanyl HCl patient-controlled transdermal system (PCTS): an alternative to intravenous patient-controlled analgesia in the postoperative setting. Clin. Pharmacokinet. 44: 1-6 (2005).
8. S. Grond, L. Radbruch, and K.A. Lehmann. Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin. Pharmacokinet. 38: 59-89 (2000).
9. K. Mystakidou, S. Befon, E. Tsilika, K. Dardoufas, S. Georgaki, and L. Vlahos. Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids. Oncology 62: 9-16 (2002).
10. R.B. Muijsers and A.J. Wagstaff. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs 61: 2289-2307 (2001).
11. W. Jeal and P. Benfield. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control. Drugs 53: 109-138 (1997).
12. A.L. Musel and E.M. Warshaw. Cutaneous reactions to transdermal therapeutic systems. Dermatitis. 17: 109-122 (2006).
13. T.L. Martin, K.L. Woodall, and B.A. McLellan. Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002-2004) J. Anal. Toxicol. 30: 603-610 (2006).
14. J.J. Kuhlman, Jr., R. McCaulley, T.J. Valouch, and G.S. Behonick. Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases. J. Anal. Toxicol. 27: 499-504 (2003).
15. T. Grobosch, S. Weniger, and D. Lampe. Fentanyl analytics in a case of fatal misuse of transdermal fentanyl. Toxichem. Krimtech. 74: 59-63 (2007).
16. R.B. Labroo, M.F. Paine, K.E. Thummel, and E.D. Kharasch. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Drug Metab. Dispos. 25: 1072-1080 (1997).
17. M. Uhl. Determination of drugs in hair using GC/MS/MS. Forensic Sci. Int. 84: 281-294 (1997).
18. W.L. Wang, E.J. Cone, and J. Zacny. Immunoassay evidence for fentanyl in hair of surgery patients. Forensic Sci. Int. 61: 65-72 (1993).
19. C.M. Selavka, A.P. Mason, C.D. Riker, and S. Crookham. Determination of fentanyl in hair: the case of the crooked criminalist. J. Forensic Sci. 40: 681-685 (1995).
20. H. Sachs, M. Uhl, G. Hege-Scheuing, and E. Schneider. Analysis of fentanyl and sufentanil in hair by GC/MS/MS. Int J Legal Med. 109: 213-215 (1996).
21. P. Kintz, M. Villain, V. Dumestre, and V. Cirimele. Evidence of addiction by anesthesiologists as documented by hair analysis. Forensic Sci. Int. 153: 81-84 (2005).
22. P. Kintz, A. Tracqui, C. Jamey, and P. Mangin. Detection of codeine and phenobarbital in sweat collected with a sweat patch. J. Anal. Toxicol. 20: 197-201 (1996).
23. P. Kintz, A. Tracqui, and P. Mangin. Sweat testing for benzodiazepines. J. Forensic Sci. 41: 851-854 (1996).
24. J.R. Taylor, I.D. Watson, F.J. Tames, and D. Lowe. Detection of drug use in a methadone maintenance clinic: sweat patches versus urine testing. Addiction 93: 847-853 (1998).
25. N. Samyn, G. De Boeck, M. Wood, C.T. Lamers, D. De Waard, K.A. Brookhuis, V.G. Verstraete, andW.J. Riedel. Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forensic Sci. Int. 128: 90-97 (2002).
26. M.J. Follador, M. Yonamine, R.L. de Moraes Moreau, and O.A. Silva. Detection of cocaine and cocaethylene in sweat by solid-phase microextraction and gas chromatography/mass spectrometry. J. Chromatogr. B 811: 37-40 (2004).
27. T. Saito, A. Wtsadik, K.B. Scheidweiler, N. Fortner, S. Takeichi, and M.A. Huestis. Validated gas chromatographic-negative ion chemical ionization mass spectrometric method for delta(9)-tetrahydrocannabinol in sweat patches. Clin. Chem. 50: 2083-2090 (2004).
28. B. Appenzeller, C. Schummer, S.B. Rodrigues, and R.Wennig. Determination of the volume of sweat accumulated in a sweat-patch using sodium and potassium as internal reference. J. Chromatogr. B 852: 333-337 (2007).
29. P. Lemmer, S. Schneider, M. Schuman, C. Omes, V. Arendt, J.C. Tayari, L. Fundira, and R. Wennig. Determination of nevirapine and efavirenz in plasma using GC/MS in selected ion monitoring mode. Ther. Drug Monit. 27: 521-525 (2005).
30. L.F. Martins, M. Yegles, H. Chung, and R. Wennig. Sensitive, rapid and validated gas chromatography/negative ion chemical ionization-mass spectrometry assay including derivatisation with a novel agent for the enantioselective quantification of amphetamine-type stimulants in hair. J. Chromatogr. B 842: 98-105 (2006).
31. J.R. Varvel, S.L. Shafer, S.S. Hwang, P.A. Coen, and D.R. Stanski. Absorption characteristics of transdermally administered fentanyl. Anesthesiology 70: 928-934 (1989).
32. F. Pragst. Pitfalls in hair analysis. Toxichem. Krimtech. 71: 69-82 (2004).
33. S. Hayashi, I. Miyamoto, and K. Takeda. Measurement of human hair growth by optical microscopy and image analysis. Br. J. Dermatol. 125: 123-129 (1991).
34. M. Yegles and R. Wennig. Opioids testing in hair. In Analytical and Practical Aspects of Drug Testing in Hair, P. Kintz, Ed. Taylor & Francis, Boca Raton, FL, 2007, pp 73-94.